Fig. 3: Recommendations for the future of prostate cancer research.
From: Engineering prostate cancer in vitro: what does it take?
A co-culture system integrating 3D engineered organoids and an organ-on-chip platform to incorporate the multiple cell types of the TME would allow development of a more physiologically relevant PCa model amenable for clinical translation and precision medicine. (Created with BioRender.com).
